Greg Bial is a seasoned professional in business development and scientific research with a diverse background in the biotechnology and pharmaceuticals sectors. Currently serving as the Director of Business Development at HitGen Inc. since April 2025, Bial previously held the position of Associate Business Development Manager at Axolabs GmbH, focusing on the transition of therapeutic oligonucleotide companies to advanced manufacturing stages. Bial's extensive experience at Yecuris Corporation includes roles such as Client Services Group Manager, Manufacturing Scientist, and Senior Associate Scientist, contributing to key projects in gene therapy and infectious disease research. Bial's career began with internships at Oregon Health and Science University and Life Technologies, complemented by a dual Bachelor of Science degree in Genetics & Cell Biology and Economics from Washington State University.
This person is not in any teams
This person is not in any offices